Compact and highly active next-generation libraries for CRISPR-mediated gene repression and activation

Author:

Horlbeck Max A1234ORCID,Gilbert Luke A1234,Villalta Jacqueline E1234,Adamson Britt1234,Pak Ryan A15ORCID,Chen Yuwen1234,Fields Alexander P1234,Park Chong Yon15,Corn Jacob E56ORCID,Kampmann Martin12347ORCID,Weissman Jonathan S1234ORCID

Affiliation:

1. Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, United States

2. Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, United States

3. California Institute for Quantitative Biomedical Research, University of California, San Francisco, San Francisco, United States

4. Center for RNA Systems Biology, University of California, San Francisco, San Francisco, United States

5. Innovative Genomics Initiative, University of California, Berkeley, Berkeley, United States

6. Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States

7. Institute for Neurodegenerative Diseases, University of California, San Francisco, San Francisco, United states

Abstract

We recently found that nucleosomes directly block access of CRISPR/Cas9 to DNA (<xref ref-type="bibr" rid="bib25">Horlbeck et al., 2016</xref>). Here, we build on this observation with a comprehensive algorithm that incorporates chromatin, position, and sequence features to accurately predict highly effective single guide RNAs (sgRNAs) for targeting nuclease-dead Cas9-mediated transcriptional repression (CRISPRi) and activation (CRISPRa). We use this algorithm to design next-generation genome-scale CRISPRi and CRISPRa libraries targeting human and mouse genomes. A CRISPRi screen for essential genes in K562 cells demonstrates that the large majority of sgRNAs are highly active. We also find CRISPRi does not exhibit any detectable non-specific toxicity recently observed with CRISPR nuclease approaches. Precision-recall analysis shows that we detect over 90% of essential genes with minimal false positives using a compact 5 sgRNA/gene library. Our results establish CRISPRi and CRISPRa as premier tools for loss- or gain-of-function studies and provide a general strategy for identifying Cas9 target sites.

Funder

Howard Hughes Medical Institute

National Institutes of Health

Leukemia and Lymphoma Society

National Cancer Institute

Li Ka Shing Foundation

National Institute of General Medical Sciences

Publisher

eLife Sciences Publications, Ltd

Subject

General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3